Artificial tissue has always lacked a key ingredient: blood vessels. A new 3-D printing technique seems poised to change that.
Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
A new brain-imaging technology may reveal the true risk of repetitive head injury in contact sports.
The decision should reduce uncertainty in the field of molecular diagnostics.
In your DNA are clues to your health, your ancestry, and maybe even your purchasing preferences.
New partnerships could help bring a novel class of biopharmaceutical to patients.
Researchers found they could tie people’s identities to supposedly anonymous genetic data by cross-referencing it with information available online.
Presage’s device would allow oncologists to test potentially harmful compounds in tiny amounts before giving patients a full dose.
A modification to existing LEDs based on firefly abdomens can boost the brightness of the light source.
Desperate to find new drugs, some pharmaceutical firms are outsourcing nearly half of their R&D budgets.
IBM's Blue Gene supercomputer uncovers a novel drug interaction site.